Quick Answer
bioAffinity Technologies, Inc. reported Net Income of -$14.91 million for fiscal year 2025.
bioAffinity Technologies, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$14.91M | -64.9% |
| 2024 | -$9.04M | -13.9% |
| 2023 | -$7.94M | +2.7% |
| 2022 | -$8.15M | -28.9% |
| 2021 | -$6.33M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.05M | -152.4% | -24.4% |
| June 30, 2025 | -$4.06M | -92.4% | -52.6% |
| March 31, 2025 | -$2.66M | -35.6% | -33.0% |
| September 30, 2024 | -$2.00M | +12.7% | +5.2% |
| June 30, 2024 | -$2.11M | -21.3% | -7.6% |
| March 31, 2024 | -$1.96M | -28.0% | +14.4% |
| September 30, 2023 | -$2.29M | +53.4% | -31.6% |
| June 30, 2023 | -$1.74M | -1876.3% | -13.5% |
- bioAffinity Technologies, Inc. showed a decrease of -64.9% in Net Income compared to the prior fiscal year.
- Over the 2021–2025 period, bioAffinity Technologies, Inc.’s net income has declined by 135.7% (from -$6.33 million to -$14.91 million).
- The most recent figure is from bioAffinity Technologies, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: